Identification of a Novel Homozygous Missense Mutation in the CLDN16 Gene to Decipher the Ambiguous Clinical Presentation Associated with Autosomal Dominant Hypocalcaemia and Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in an Indian Family
Calcified Tissue International · 11.12.2023 · 114 (2) · 110-118
DOI: 10.1007/s00223-023-01142-8 ↗Kurz gefasst
Fallbericht in der Zeitschrift Calcified Tissue International, online erschienen am 11.12.2023. Verfasst von Rupesh Thapa und 3 weiteren Autor:innen. Beteiligte Einrichtung: The University of Burdwan, Burdwan, WB, India. Hauptthemen laut MEDLINE: Nephrocalcinosis, Hypocalcemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Institute of Biomedical Genomics.
Abstract (Originalsprache)
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHNNC) is a rare autosomal recessive renal tubulopathy disorder characterized by excessive urinary loss of calcium and magnesium, polyuria, polydipsia, bilateral nephrocalcinosis, progressive chronic kidney disease, and renal failure. Also, sometimes amelogenesis imperfecta and severe ocular abnormalities are involved. The CLDN-16 and CLDN-19 genes encode the tight junction proteins claudin-16 and claudin-19, respectively, in the thick ascending loop of Henle in the kidney, epithelial cells of the retina, dental enamel, etc. Loss of function of the CLDN-16 and/or CLDN-19 genes leads to FHHNC. We present a case of FHHNC type 1, which was first confused with autosomal dominant hypocalcaemia (ADH) due to the presence of a very low serum parathyroid hormone (PTH) concentration and other similar clinical features before the genetic investigations. After the exome sequencing, FHHNC type 1 was confirmed by uncovering a novel homozygous missense mutation in the CLDN-16 gene (Exon 2, c.374 T > C) which causes, altered protein structure with F55S. Associated clinical, biochemical, and imaging findings also corroborate final diagnosis. Our findings expand the spectrum of the CLDN-16 mutation, which will further help in the genetic diagnosis and management of FHNNC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The University of Burdwan, Burdwan, WB, India.
- National Institute of Biomedical Genomics, Kalyani, WB, India.
- Department of Paediatric Medicine, Burdwan Medical College, and Hospital, Burdwan, WB, India.
- Department of Paediatric Medicine, Burdwan Medical College, and Hospital, Burdwan, WB, India. kaustav25@yahoo.co.in.
- The University of Burdwan, Burdwan, WB, India. abasu@zoo.buruniv.ac.in.
- National Institute of Biomedical Genomics, Kalyani, WB, India. abasu@zoo.buruniv.ac.in.
Förderung
- National Institute of Biomedical Genomics
Zitieren
APA
Thapa, R., Roy, A., Nayek, K., & Basu, A. (2023). Identification of a Novel Homozygous Missense Mutation in the CLDN16 Gene to Decipher the Ambiguous Clinical Presentation Associated with Autosomal Dominant Hypocalcaemia and Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in an Indian Family. Calcified Tissue International, 114(2), 110-118. https://doi.org/10.1007/s00223-023-01142-8
Vancouver
Thapa R, Roy A, Nayek K, Basu A. Identification of a Novel Homozygous Missense Mutation in the CLDN16 Gene to Decipher the Ambiguous Clinical Presentation Associated with Autosomal Dominant Hypocalcaemia and Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in an Indian Family. Calcified Tissue International. 2023;114(2):110-118. doi:10.1007/s00223-023-01142-8
BibTeX
@article{Thapa2023,
author = {Thapa, Rupesh and Roy, Amaresh and Nayek, Kaustav and Basu, Anupam},
title = {Identification of a Novel Homozygous Missense Mutation in the CLDN16 Gene to Decipher the Ambiguous Clinical Presentation Associated with Autosomal Dominant Hypocalcaemia and Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in an Indian Family},
journal = {Calcified Tissue International},
year = {2023},
volume = {114},
number = {2},
pages = {110--118},
doi = {10.1007/s00223-023-01142-8}
}
EUVIMED